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In the nematode Caenorhabditis elegans, the BMP-related growth factor DBL-1 regulates body size and male tail morphogenesis via a
conserved receptor/Smad signaling pathway. Smads are transcription factors, but rely on transcription cofactors for appropriate regulation of target
genes in response to TGF-β- and BMP-related signals. In the DBL-1 pathway, sma-9 encodes multiple zinc finger transcription factors
homologous to Drosophila Schnurri, which functions in Dpp/BMP signaling. We have studied the molecular functions of SMA-9 as a model for
transcription cofactor-dependent regulation of gene expression. Using SMA-9 fusions to known transcriptional activators and repressors, we
demonstrate that SMA-9 acts primarily as a transcriptional repressor in body size regulation in vivo. In contrast, both activator and repressor
functions contribute to male tail patterning. We further show that different SMA-9 regions have intrinsic repressor and activator activities using a
yeast transcription assay. We use microarray analysis to identify transcriptional target genes in body size regulation. Consistent with the
importance of repression in mediating body size regulation, we find more repressed genes than activated genes in this pool. Finally, we identify
five transcriptional targets with body size and/or male tail patterning phenotypes, including transcription factors related to Runx and fos and
signaling molecules related to hedgehog and patched. Our results thus suggest that SMA-9 products function differentially as transcriptional
repressors and activators in DBL-1/BMP pathway regulated body size and male tail morphogenesis.
© 2007 Elsevier Inc. All rights reserved.Keywords: sma-9; BMP; Schnurri; Transcriptional repressor; Transcriptional activator; DNA microarray; Gene regulation; Body sizeIntroduction
Cell signaling pathways can elicit appropriate responses
either by direct modification of cellular components, such as the
cytoskeleton, or by the modulation of cell transcription profiles.
Smads are signal transducers for transforming growth factor-
beta (TGF-β) superfamily ligands that function by regulating
gene transcription. Since DNA binding sites for Smads show
low complexity and affinity, transcriptional cofactors are often
required for target gene regulation (Shi et al., 1998; Massague,
1998; Derynck and Zhang, 2003). Smad complexes activate or⁎ Corresponding author. Fax: +1 718 997 3445.
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doi:10.1016/j.ydbio.2007.02.038repress gene transcription depending on whether they associate
with transcriptional activators or repressors. We have previously
identified a gene, sma-9, that encodes a putative transcription
cofactor in the DBL-1 signaling pathway in the nematode
Caenorhabditis elegans. SMA-9 protein products show motifs
consistent with a role in transcriptional regulation, including a
Gln-rich domain, seven zinc finger motifs, an acidic residue-rich
domain and nuclear localization signals (Liang et al., 2003).
Furthermore, SMA-9 is homologous to Drosophila Schnurri
(Shn), which has been proposed to function as a transcription
factor in Dpp signaling. Three vertebrate homologs of Schnurri
have also been identified. These bind the κB-binding site and
function in Tcell development (Takagi et al., 2001; Oukka et al.,
2002; Wu, 2002). Like sma-9, human Shn-1 and Shn-3 genes
undergo alternative splicing (Muchardt et al., 1992; Hicar et al.,
2001). Notably, Shn-1 and Shn-2 have recently been demon-
strated to play a role in BMP-dependent transcriptional regu-
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(Yao et al., 2006; Jin et al., 2006). In this study, we have
addressed the molecular mechanisms of SMA-9 function in
BMP-related signaling in C. elegans.
C. elegans DBL-1 (Dpp and BMP-like) is a member of the
TGF-β superfamily closely related to Drosophila Dpp and
vertebrate BMP-2/BMP-4 (Suzuki et al., 1999). The DBL-1
signaling pathway regulates body size and patterning of male-
specific copulatory structures (Savage-Dunn, 2005). DBL-1
pathway loss of function (lf) mutants have small body size in
both hermaphrodites and males (Sma phenotype). In addition,
the mutant male has abnormal male tail sensory ray fusions and
crumpled spicules (Mab phenotype) (Savage et al., 1996). Wild-
type male tails have an acellular structure called the fan, which
is formed from the cuticle matrix (Sulston et al., 1980). Within
the fan, there are two sets of nine sensory rays distinguished by
their specific positions and shapes. DBL-1 pathway (lf) mutant
males have frequent ray fusions of rays 4–5, 6–7, and 8–9.
Furthermore, in these mutants, the pair of copulatory spicules
necessary for mating are crumpled with 100% penetrance.
When dbl-1 is overexpressed in a wild type background, the
animal has a long body size (Lon phenotype) and the male
contains ray 3–4 fusions (Suzuki et al., 1999). sma-9 functions
as a downstream component of the DBL-1 pathway. Like other
DBL-1 pathway components, sma-9(lf) mutants have small
body size and abnormal male tails. Phenotypic analysis shows
that sma-9 regulates body size development specifically in early
larval stages and regulates morphogenesis of only sensory rays
8 and 9 (Liang et al., 2003). In addition to these roles in body
size and male tail patterning, sma-9 has recently been reported
to regulate mesodermal cell lineages, a role in which sma-9
antagonizes DBL-1 pathway function (Foehr et al., 2006).
In Drosophila, early reports attributed to Shn roles as both a
transcriptional activator and a transcriptional repressor (Dai et
al., 2000; Marty et al., 2000; Torres-Vazquez et al., 2001). Some
studies have suggested that the principle role of Shn is to
repress expression of brinker (brk), a transcriptional repressor
of Dpp target genes (Marty et al., 2000; Muller et al., 2003).
However, brk is not a conserved gene, and to date, no brk
homolog has been found in C. elegans or other genomes. More
recently, Pyrowolakis et al. (2004) reported that transcriptional
repression of brk is dependent on a short cis-acting silencer
element (SE). The SE has high affinity for the Smads Mad and
Medea, which subsequently recruit the transcriptional repressor
Shn. The authors found that many Dpp pathway target genes
contain this sequence, which suggests a brk-independent
transcriptional repressor activity of Shn. However, whether
Shn contributes to the transcriptional repression of these genes
has in most cases not been tested. In an elegant extension to this
work, Yao et al. (2006) have reported that vertebrate Shn-1
regulates the Xenopus BMP target gene Xvent2 via a sequence
homologous to the SE. In this system, Shn functions as a
transcriptional activator rather than as a repressor. By exchan-
ging Drosophila and Xenopus Shn genes in these experiments,
they demonstrate that transcriptional activation or repression
may be context-dependent rather than an intrinsic property of
the protein.None of these previous studies have determined whether
transcriptional repressor or activator activities are sufficient to
mediate Shn functions throughout development, rather than in
the context of selected target genes, nor have studies addressed
the intrinsic transcriptional activities of Shn proteins. To address
the nature of the SMA-9 transcriptional activity, we have used
transgenic and DNA microarray approaches. These approaches
are facilitated in C. elegans relative to other systems, such as
Drosophila and vertebrates, because DBL-1 pathway mutants
are viable. We have created SMA-9 fusions to known
transcriptional activator and repressor domains. The transcrip-
tional repressor fusion partially rescued sma-9 mutant pheno-
types in all tissues tested, and caused a ligand overexpression
phenotype in the male tail. The transcriptional activator fusion
acted as a dominant negative in body size, but partially rescued
the male tail phenotypes. Additionally, we have shown that
regions of SMA-9 have intrinsic transcriptional repressor and
activator activities. Finally, we have used DNA microarray
analysis to identify target genes of dbl-1 and sma-9 involved in
early larval development, when sma-9 is active in regulating
body growth. This analysis expands substantially on a previous
smaller-scale screen of transcriptional target genes for this
pathway using arrayed cDNAs (Mochii et al., 1999). In our
microarray positives, there are more genes transcriptionally
repressed than activated. We identified conserved and novel
transcriptional target genes, including homologs of Runx and
bZIP transcription factors. Notably, we demonstrate that
T27F2.4, a C. elegans homolog of the mouse gene fosB, is a
downstream negative regulator of DBL-1 pathway-regulated
development. Taken together, these experiments suggest that
sma-9 provides transcriptional repressor activity to regulate
body size, while contributing both repressor and activator
activities for the regulation of male tail patterning.
Materials and methods
Strains
C. elegans strains were cultured using standard methods and grown at 20 °C
(Brenner, 1974). In addition to strains generated in this work, the following were
used: N2 (wild type), LG II: sma-6(wk7); LG III: sma-2(e297), sma-3(wk30),
sma-4(e729); LG IV: dbl-1(wk70); LG V: him-5(e1490); LG X: sma-9(wk55).
Since sma-9(wk55) has the strongest loss of function phenotype, most of our
work was done on this strain.
Molecular cloning
En and VP-16 fusions: 4.0 kb sma-9 promoter region (Liang et al., 2003) was
cloned in pBluescript SK+ at NotI and SacII sites (pCS301); and then 3.6 kb
sma-9 C-terminal genomic sequence, from the first zinc finger region to the stop
codon, was cloned into pCS301 at SpelI and KpnI sites (pCS303); finally VP-16
(370 bp) or Engrailed (900 bp) transcription activity domain (from vector TCF-
vp16 and TCF-Engrailed (gifts from Gary Struhl)) was inserted into pCS303 at
NotI and SpelI sites (pCS304 – VP-16-sma-9; pCS305 – en-sma-9), respectively.
sma-9 ARD II and cDNA clones yk1285a11 and pCS272 were cloned into
yeast vector pSH 2-1, which give rise to pCS327, pCS326, and pCS330,
respectively. These constructs were cotransfected with pLGΔ312S and pJK1621
(gifts from S. Kuchin) into yeast strain MCY 829. Yeast transcription activity
was performed as described (Kuchin and Carlson, 2003). Heat-shock vector
pPD49.83 was a kind gift from Dr. Liu. yk1285a11 and yk1237d01 was cloned
into pPD49.83 at NheI and KpnI.
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T27F2.4 ORF was cloned into pBluescript SK+ and RNAi feeding vector
pPD129.36 (a gift from A. Fire), respectively, at SacI and KpnI sites, which
generated pCS359 and pCS360.
All primer sequences are available on request.
Transgenic animals and RNAi
Microinjection was done by standard procedures using rol-6 as a marker
(Melloetal.,1991).Arrayswereintegratedusingγ-irradiation.Transgenicanimals
carrying pCS305 (en-sma-9) are CS331 – sma-9(wk55);him-5(e1490);qcIs25;
CS332 – sma-9(wk55);him-5(e1490);qcIs26; CS333 – sma-9(wk55);him-5
(e1490);qcIs27; CS334 – sma-9(wk55);him-5(e1490);qcIs28; CS491 – him-5
(e1490);qcIs26; carryingpCS304 (VP-16-sma-9) areCS488– sma-9(wk55);him-
5(e1490);qcIs33 and CS336 – him-5(e1490);qcIs30; CS337 – him-5(e1490);
qcIs31; CS338 – him-5(e1490);qcIs32; CS339 – him-5(e1490);qcIs33; carrying
pCS255 (1.5 kb sma-9∷gfp) is CS301 – him-5(e1490);qcIs20; carrying pCS251
(2.8 kb sma-9∷gfp) is CS304 – him-5(e1490);qcIs23; and carrying pCS256
(4.0 kb sma-9∷gfp) is CS303 – him-5(e1490);qcIs22. Vectors pCS251,
pCS255, and pCS256 are described in the study of Liang et al. (2003). CS332
and CS339 are the representative transformed animal strains, which give rise to
the similar phenotype as others. Transgenic animals carrying yk1285a11 and
yk1237d01 are CS486 and CS482, respectively. dsRNA was made from
pCS359 as described (Liang et al., 2003). RNAi feeding method using pCS308
and pCS360 was performed as described (Kamath and Ahringer, 2003). For
the growth curve, RNAi hypersensitive rrf-3 mutants were fed T27F2.4
dsRNA.
Heat-shock experiments
Gravid hermaphrodites were washed off plates with M9 buffer and collected
in an Eppendorf tube. Hermaphrodites were destroyed with sodium hypochlorite
solution, leaving eggs that were collected and inoculated onto OP50-seeded
plates. For male tail ray examination, 72 h after egg collection, collect and
transfer the worms to a siliconized Eppendorf tube containing 100 μl of M9
buffer (Brenner, 1974), which was placed in a circulating water bath under the
heat-shock conditions specified. After heat-shock, worms were recovered,
placed at 25 °C on OP50-seeded plates and allowed to develop to adulthood and
then scored for ray patterning.
DNA microarray analysis
sma-9(wk55), dbl-1(wk70), and wild type N2 (as control) were grown on
150 mm plates; eggs were collected by treating the adult animals with
hypochlorite; incubated at 20 °C until worms developed to L2 (staged by
examining VPC and gonadal lineages using Nomarski optics); and harvested.
Total RNA was extracted by standard methods using Trizol. Gene Chip C.
elegansGenome Arrays were purchased from Affymetrix (Lot 3005451), which
contains about 22,150 unique transcripts. At least duplicate experiments were
performed on each strain. Hybridization and scanning were performed by Core
Laboratory (GCL) at Memorial Sloan-Kettering Cancer Center. The software
used for analyzing data were: GCOS (downloaded from Affymetrix Company)
and the Macro program (developed by GCL Memorial Sloan-Kettering Cancer
Center). Microarray data have been submitted to ArrayExpress (accession
number e-mexp-687).
Genes were selected that showed at least 2-fold changes (microarray
difference P<0.001) of expression level in pairwise comparison with wild type.
To determine the accuracy of the microarray results, we performed quantitative
real-time RT–PCR on 10 selected genes (Supplementary Table 1). For five of
the ten genes, the RT–PCR results confirmed the microarray results for both
genetic backgrounds, an additional three genes were confirmed in one of the two
genetic backgrounds, and two genes were found to be false positives. We then
performed Student's t-test analysis on our microarray data. Elimination of genes
with t-test P values >0.05 effectively removes one of the two false positives,
msp-152, and inconsistent results for rnt-1. This stringency of statistical cutoff
may also eliminate some true positives, such as T27F2.4 in the dbl-1
background and fat-7 in both backgrounds, but leaves us with greaterconfidence in the remaining group. Therefore, we report here genes that meet
the criteria of fold change of ≥2 and t-test P value ≤0.05 (Tables 2–4).
RT–PCR
Total RNA was isolated by Trizol (GibcoBRL) from wild type, sma-9
(wk55), the transformed strains CS332 and CS339. RT–PCR was performed
using SUPERSCRIPT™ One-Step RT–PCR (Invitrogen). Real-time PCR was
performed on LightCycler 2.0 version (Roche). Primers were designed by
LightCycler Probe Design Software 2.0. Data Analysis software used was
LightCycler software 4.0 version. N2, sma-9(wk55), and dbl-1 (wk70) animals
were synchronized to L2 as described above. Total RNA was extracted from
these animals by Trizol as above. SuperScript™ III platinum two-step qRT–
PCR kit with SYBR Green was used to perform RT–PCR. A total of 10 genes
was examined both in sma-9 and dbl-1 background. Gene act-1 was used as
standard control. The intron primer of act-1 gene was used to test for the
presence of genomic DNA. The results showed that total RNAwas pure without
contamination of genomic DNA.Results
SMA-9 transcriptional repressor fusion rescues body size
To investigate whether sma-9 acts as a transcriptional
activator or repressor in the DBL-1 pathway, two artificial
sma-9 constructs were created, VP-16-sma-9 and en-sma-9.
sma-9 genomic sequences encoding the zinc finger domains
that are putative DNA binding domains were fused with either
VP-16 or Engrailed (En) transcription activity domain, and
expression driven by previously characterized sma-9 promoter
sequences. Since VP-16 and En have been shown to be a strong
transcriptional activator and repressor, respectively (Sze et al.,
1997; Tolkunova et al., 1998), VP-16-SMA-9 and En-SMA-9
would act as a transcriptional activator and repressor,
respectively. Then, these constructs were microinjected into
both sma-9(lf) and wild type animals. Both the Sma and Mab
phenotypes of the transformed animals were investigated. We
used RT–PCR with transgene-specific primers to confirm
expression of the fusion constructs (Fig. 1).
The sma-9(lf) mutants with en-sma-9 constructs show
significant rescue of the body size defect (Fig. 1A). In contrast,
VP-16-sma-9 transformed into either sma-9(lf) or wild type
animals results in a significant reduction in body size (Fig. 1A).
These results suggest that for body size regulation, en-sma-9
can substitute for functional sma-9, whereas VP-16-sma-9 acts
as a dominant negative.
Both SMA-9 transcriptional repressor and activator fusions
partially rescue male tail defects
In sma-9(lf) mutants with en-sma-9, the male tail ray 8 and 9
fusions were improved from 53% frequency to 29%, and
crumpled spicules were partially rescued from 46% frequency
to 8% (Table 1). Meanwhile a dbl-1 overexpression phenotype,
ray 3 and 4 fusion, was observed (Fig. 1B). Unlike in body size
regulation, VP-16-sma-9 expression resulted in a partial rescue
of sma-9 male tail defects, reducing fusions from 53% to 36%
(Table 1). Thus, in the male tail, repressor fusions and activator
fusions can both partially substitute for endogenous SMA-9. We
Fig. 1. sma-9 functions as a transcriptional repressor in DBL-1 pathway
regulated body size. (A) Growth curve of sma-9(wk55) animals transformed
with en-sma-9 (square), VP-16-sma-9 (triangle), and control (diamond); and
wild type animals transformed with VP-16-sma-9 (star) and control (cross). The
en-sma-9 transformed animals are larger than sma-9, indicating that it partially
rescues the body size. Meanwhile, VP-16-sma-9 transformed animals are
smaller than control animals. (B) En-sma-9-transformed animal gave rise to rays
3–4 fusion, which was reported in dbl-1 overexpression strains (Suzuki et al.,
1999). The fusion has a higher penetrance in sma-9(+) than in sma-9(lf)
animals. (C) Detection of en-sma-9 mRNA. (D) Detection of VP-16-sma-9
mRNA. The transcript from fusion constructs was detected by RT–PCR in
transgenic strains en-sma-9 (C-3), sma-9;VP-16-sma-9 (D-2), and VP-16-sma-
9 (D-3), but not in untransformed wild type (C-1; D-1) backgrounds. en-sma-9
expression was not detected in the sma-9 mutant background (C-2), but rescue
was observed in this strain, suggesting that the transgene was expressed at a low
but sufficient level.
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both transcriptional repressor and activator functions, and that
these functions may be differentially required in different
tissues.
Transcriptional activity of SMA-9 protein fragments
To test whether SMA-9 protein products have intrinsic
transcriptional activity, we performed a transcription activityassay in yeast (Table 2). SMA-9 fragments were chosen that
contained possible transcriptional activity domains but not zinc
finger motifs, to avoid intrinsic DNA binding activity. The
cDNA clone yk1285a11 contains the 5′ Gln-rich domain,
pCS272 contains 5′ sequences but excludes theGln-rich domain,
and ARD II contains the second acidic residue-rich domain in
predicted exons 14 and 15. The vector pLGΔ312S constitutively
expresses the lacZ gene whose expression level can be measured
by β-Galactosidase (β-Gal) activity. Vectors pJK1621 is a
derivative that contains four LexA operators upstream of the
UAS. The tested SMA-9 fragments were fused with LexA DNA
binding domain in yeast vector pSH 2-1. After cotransformation,
the tested protein fragment should influence lacZ expression via
interaction between LexA DNA binding domain and its
operator. In the yeast assay, yk1285a11 did not demonstrate
transcriptional activity (data not shown). pCS272 decreased
activity 2.3-fold (Table 2), demonstrating that this N-terminal
fragment has transcriptional repressor activity. In contrast, the
ARD II fragment causes a 1.2-fold increase of β-Gal expression
(Table 2). This indicates that ARD II contains weak transcrip-
tional activator activity. Interestingly, the cDNA clone
yk1237d01 contains an SL2 splice leader and polyA tail,
representing a short but complete 3′ sma-9 transcript. Since this
form excludes N-terminal sequences but contains ARD II and
the putative DNA binding domain, it may have transcriptional
activator activity in vivo (Fig. 2).
To test the activities of these SMA-9 regions in vivo, we
expressed the 5′ and 3′ cDNAs yk1285a11 and yk1237d01 in
sma-9(wk55) using a heat-shock promoter. After heat-shock,
the 3′ cDNA yk1237d01, but not the 5′ clone yk1285a11, was
able to provide rescuing activity in the male tail (Table 1). In fact,
the degree to which yk1237d01 rescues the frequency of ray 8–9
fusions is strikingly similar to the degree of rescue by the VP-16-
SMA-9 fusion. These results are consistent with the hypothesis
that this cDNA encodes a shorter SMA-9 isoform that
specifically provides transcriptional activator activity in vivo.
More genes were repressed than were activated in DNA
microarray expression profiles
To identify potential dbl-1 and sma-9 transcriptional target
genes regulating body size, we determined patterns of gene
expression using a DNA microarray. Since sma-9 functions in
early larval stages in body size regulation (Liang et al., 2003),
L2 animals were used to perform DNA microarray analysis. In
this analysis, we would be unlikely to find target genes
specifically involved in male tail development, since our
populations did not include a significant proportion of males.
Because the animals used are loss of function mutants, genes
upregulated in the mutant backgrounds are repressed by the
specific gene activity in the wild type background, while genes
downregulated in the mutant backgrounds are activated by the
specific genes. The genes identified include both direct and
indirect target genes.
We identified genes with ≥2-fold change in expression
levels by microarray analysis (Materials and methods). Micro-
array positives were further culled by Student's t-test, p≤0.05.
Table 1
Male tail phenotypes in sma-9 transgenic animals
Strain Ray 3–4 fusion (%) Ray 8–9
fusion (%)
n (sides) Crumpled
spicules (%)
n (tails) Ectopically expressed
product
Wild type 0 16 74 0 30 None
qcIs26 Occasionally Observed 11 88 0 52 En-SMA-9
qcIs33 0 8 74 0 30 VP-16-SMA-9
sma-9 0 53 101 46 50 None
sma-9;qcIs26 Occasionally Observed 29 ∗∗ 87 8** 36 En-SMA-9
sma-9;qcIs33 0 36 ∗ 50 ND ND VP-16-SMA-9
sma-9;qcEx118 0 70 20 ND ND yk1285a11 (5′)
sma-9;qcEx119 0 34** 85 ND ND yk1237d01 (3′)
All strains contain him-5(e1490). The sma-9 allele used is wk55.
⁎ Significant rescue: p<0.05 compared to sma-9 mutant background.
⁎⁎ Highly significant rescue: p<0.01 compared to sma-9mutant background.
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RT–PCR (Supplementary Table 1) to confirm the validity of our
statistical criteria. Based on RT–PCR results, these stringent
criteria likely underestimate the total pool of target genes and, in
particular, the overlap between dbl-1- and sma-9-regulated
targets. The remaining pool, however, provide a core of target
genes in which we have a high degree of confidence. By these
criteria, a total of 242 genes has altered expression in dbl-1
mutants and 146 genes in sma-9mutants, of which 31 genes are
in common between both backgrounds (Fig. 3). Since sma-9
regulates fewer genes than dbl-1, these data are consistent with
our previous hypothesis that sma-9 regulates a subset of DBL-1
pathway target genes. We propose that in order to fulfill the
complete function of the DBL-1 pathway, the Smad complex
needs SMA-9 and other transcriptional cofactors. A previously
reported smaller-scale study of the DBL-1 pathway using
arrayed cDNAs identified 24 genes commonly regulated by
dbl-1 and sma-2 (Mochii et al., 1999). Of these 24 genes, 4
were also identified in our screen (C08E3.13, F35C5.9,
K01A2.3, and K05G3.3; Tables 2–4). Differences in the two
sets of genes may be due in part to stage-specific differences in
expression.
Among the 146 genes directly or indirectly regulated by
sma-9, 107 genes are repressed and 39 genes are activated.
These results are consistent with our hypothesis that sma-9
functions as a transcriptional repressor in body size regulation.
We expected that DBL-1 activity would cause the repression of
some target genes, possibly mediated by SMA-9, and theTable 2
sma-9 fragment transcriptional activity
Fragment β-Gal activity a Fold
change b−LexA op +LexA op
LexA 99 86 −1.15
pCS272-LexA 871.1±61.1 378.9±26.7 −2.3
ARD II-LexA 1512.7±198.6 1826.3±346.3 +1.2
a β-Galactosidase activity was assayed in permeabilized cells and expressed
in Miller units: Activity= (OD420×1000) / (OD600×vol. assayed× time in min)
for three to four independent clones.
b Fold change was calculated as the ratio of the values obtained for reporters
with and without a LexA operator. ‘−’: repression; ‘+’: activation. The host
strain was MCY 829.activation of a greater number of target numbers. Surprisingly,
among the 242 genes regulated by dbl-1, 159 genes are
repressed but only 83 genes are activated. This suggests that in
early larval stages in hermaphrodites, the DBL-1 pathway
primarily represses target gene expression. We tested the
hypothesis that the DBL-1 pathway represses target gene
transcription by stimulation of sma-9 expression, which then
acts as a transcriptional repressor. Different sma-9 transcrip-
tional reporter genes (Liang et al., 2003) were introduced into
dbl-1, sma-6, sma-2, sma-3, and sma-4. However, none of
them had a significant expression change compared with wild
type (data not shown). Also, sma-9 is not regulated by dbl-1
from our microarray analysis. Thus, we exclude the possibility
that the DBL-1 pathway represses target gene transcription by
regulating sma-9 expression level. Taken together, we propose
that sma-9 regulates a subset of DBL-1 pathway genes and
functions primarily as a transcriptional repressor in body size
regulation.
Target genes involved in body size regulation
Five of our identified target genes have a demonstrated body
size phenotype. One gene negatively regulates body size: the
fos-related basic-leucine zipper transcription factor T27F2.4,
for which we have identified a Lon phenotype in RNAi
experiments (see below). Another predicted transcription factor
gene, rnt-1, regulated body size and was upregulated in sma-9
mutants. rnt-1 encodes the only homolog of mammalian AML/
RUNX genes in C. elegans (Nam et al., 2002). Partial loss of
function rnt-1 mutants are small and their male tails have a
broad range of defects in rays 1 to 9 but do not have a defect in
the spicules (Ji et al., 2004; Nimmo et al., 2005). Both of these
defects may be due in part to disruptions in cell divisions of the
seam cells (Nimmo et al., 2005). Mammalian Runx genes, also
known as acute myeloid leukemia (AML), encode the DNA-
binding α-chain of the heterodimer core-binding factor (CBF)
complex. Runx1 is a frequent target of chromosome transloca-
tion in human leukemia especially childhood acute myeloid
leukemia (Mitani, 2004). Runx2 has been reported to interact
with Smads and regulate TGF-β type I receptor expression
(Selvamurugan et al., 2004; Ji et al., 1998). In addition, TGF-β
activates Runx genes at both transcriptional and post-
Fig. 2. Schematic of DNA constructs used in this study. sma-9 cDNA fragments (pCS272 and ARD II) that were examined for transcriptional activity. The predicted
sma-9 genomic structure and structure of representative cDNA clones is shown above.
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RT–PCR results confirmed upregulation of rnt-1 in dbl-1 and
sma-9 mutant backgrounds (Supplementary Table 1). Thus,
we propose that rnt-1 may be a downstream target gene of the
DBL-1 pathway. Since double mutants of rnt-1 and sma-2,
sma-3, sma-4, and sma-6 showed a much shorter body size and
more severe male ray fusion than single mutants (Ji et al., 2004)Fig. 3. Classes of genes identified from DNA microarray analysis regulated by dbl-1
expression is altered in sma-9 mutants. (C) Genes whose expression is altered in dband rnt-1 mutants have additional defects (Nimmo et al., 2005),
we suggest that additional inputs other than the DBL-1 pathway
also impinge on rnt-1 function.
Our data showed two hedgehog-related genes and two
patched-related genes, i.e., wrt-4, wrt-9, ptc-3, and ptr-22,
regulated by the DBL-1 pathway (Table 3). Among these four
genes, three have been shown to regulate body size (Zugastiand sma-9. (A) Common genes regulated by dbl-1 and sma-9. (B) Genes whose
l-1 mutants.
Table 3
Target genes of the DBL-1 pathway identified by microarray analysis
Gene name Identification Average fold change Background Reference a
Body size regulation
T27F2.4 fos-related basic-leucine zipper (bZIP)
transcription factor
4.33 sma-9
rnt-1 Homolog of mammalian AML/RUNX genes 3.31 sma-9
ptc-3 Patched related family −2.38 dbl-1 Liu et al., 2004
ptr-22 Patched related family 3.22 dbl-1
wrt-4 Warthog −2.95 dbl-1 and sma-9 Liu et al., 2004
Other hedgehog/patched
wrt-9 Warthog −2.14 dbl-1
Cell cycle
C04C3.4 G2/Mitotic-specific cyclin A 2.75 dbl-1
T07F10.5 G2/Mitotic-specific cyclin A 2.64 dbl-1
mcm-7 DNA replication licensing factor −2.07 dbl-1
Collagens
col-141 Cuticular collagen (type IV and type XIII) 3.19 dbl-1
rol-6 Cuticular collagen (type IV and type XIII) −2.15 dbl-1
col-41 Cuticular collagen (type IV and type XIII) −2.64 dbl-1
Innate immunity
nlp-29 Neuropeptide-like protein 3.38 sma-9 Mallo et al., 2002
pgp-1 Multidrug/pheromone exporter,
ABC superfamily
−2.57 dbl-1
B0218.8 C-type lectin −2.79 dbl-1 and sma-9 Murphy et al., 2003
pgp-6 Multidrug/pheromone exporter,
ABC superfamily
−2.89 dbl-1
T07D10.4 C-type lectin −2.95 dbl-1 Murphy et al., 2003
F35C5.9 C-type lectin −3.85 dbl-1 and sma-9 Mochii et al., 1999
lys-10 Lysozyme −4.27 sma-9
Aging genes
vit-5 Yolk protein 15.51 dbl-1 Murphy et al., 2003;
Halaschek-Wiener et al., 2005
vit-6 Yolk protein 5.29 dbl-1 Halaschek-Wiener et al., 2005
fat-6 Acyl-CoA desaturase −3.25 dbl-1 Murphy et al., 2003;
Halaschek-Wiener et al., 2005
Germline
gld-3 Defective in germ line development 19.59 dbl-1
B0280.5 A direct target of GLD-1 3.70 sma-9
gld-1 Defective in germ line development 2.20 sma-9
iff-1 Initiation factor 5 (eIF-5A) homologs 2.43 dbl-1 and sma-9
rec-8 A meiosis-specific cohesin complex subunit 2.22 sma-9
fog-3 Feminization of germ line 2.00 sma-9
glh-2 Germ line helicase 2.00 sma-9
cav-1 Caveolin protein family −2.98 dbl-1 and sma-9
a Other published expression studies.
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(patched and smoothened) play an essential role in Drosophila
and vertebrate development (Tabata and Takei, 2004). The
genetic interaction between Hh and BMPs has been extensively
studied in other organisms (Tabata and Takei, 2004; Roussa and
Krieglstein, 2004; Silver and Rebay, 2005). However, how the
two signaling pathways interact with each other in C. elegans is
poorly understood. Worm Hh homologs contain highly
conserved C-terminus (hog), but various N-termini with low
similarity. They are classified into different groups based on theirN-terminal sequence as: warthog (wrt), groundhog (grd),
groundlike (grl), and hh (Aspock et al., 1999). There are two
families of Hh receptor in the C. elegans genome, namely
patched (ptc) and patched-related (ptr). Of particular interest
among these genes is wrt-4, whose change in expression levels
was significant in both dbl-1 and sma-9 mutants and
reproducible by RT–PCR (Supplementary Table 1). Interest-
ingly, wrt-4 and ptc-3 were also listed in TGF-β dauer pathway-
regulated genes (Liu et al., 2004), suggesting crosstalk between
these pathways.
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pathway mutants
In both the microarray and RT–PCR analyses, the
uncharacterized bZIP gene T27F2.4 was upregulated in dbl-
1 and sma-9 mutant backgrounds, although the t-test showed
marginal significance for the microarray expression change in
dbl-1 (P=0.1024). To characterize this gene's regulation
further in vivo we created a reporter construct. Significantly,
T27F2.4p∷GFP has a stronger expression in sma-9, dbl-1,
and sma-6(lf) mutants compared with wild type (Figs. 4A–E).Fig. 4. T27F2.4 negatively regulates body size downstream of the DBL-1 pathway.
mutants. In wild type (A), neuronal expression were observed at larval stages but dis
pathway mutants (data not shown). T27F2.4 intestine expression was almost undete
intestine expression was observed in adult (B); while a low intestine expression wa
T27F2.4 in intestine (D) as in sma-9. In sma-6(wk7) mutants, the intestine express
higher than in wild type (E). (A′–E′) Nomarski images of animals in panels A–E. (F–
(F). T27F2.4 dsRNAi adults (G) are longer than control (H), indicating that it mighThis result supports the interpretation that T27F2.4 is an actual
target of the DBL-1 pathway. Both in wild type and DBL-1
pathway mutants, T27F2.4p∷GFP expression in neuronal cells
was first observed at the L1 larval stage and then slowly
disappeared after L4 (Fig. 4B). In wild type, a very weak
expression in intestine was observed only in adults. However, in
all DBL-1 pathway mutants a much stronger expression in
intestine occurred after L4 stages (Figs. 4A, C, D). Interestingly,
a weak expression in intestine was observed only in sma-9
mutant background during early larval stages, possibly correlat-
ing with the highly significant change in expression in this(A–E) T27F2.4 expression level was significantly changed in DBL-1 pathway
appeared in adulthood. The same neuronal expression was displayed in DBL-1
ctable in wild type background. However, in sma-9(wk55) background a high
s detected in larval stages (C). dbl-1(wk70) animal expressed a similar level of
ion is lower compared with dbl-1 and sma-9; however, it is still significantly
H) Growth curve showing long body size phenotype of T27F2.4 RNAi animals
t be a negative regulator of DBL-1 pathway regulated body size.
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array analysis. The intestine is a common site of expression for
DBL-1 pathway signaling components (Savage-Dunn, 2005)
and identified target genes (Mochii et al., 1999), though it is not
the focus of body size regulation (Inoue and Thomas, 2000;
Yoshida et al., 2001; Wang et al., 2002). Based on only a
transcriptional reporter construct, however, we cannot exclude
the possibility that T27F2.4 is also expressed elsewhere, such as
in the hypodermis.
To further investigate the function of T27F2.4 in the DBL-1
pathway, dsRNAi was performed (Fig. 4). After microinjection
of T27F2.4 dsRNA in him-5, body size was slightly longer than
control (Fig. 4G); and male tails contained a ray 3–4 fusion
similar to that displayed in ligand overexpression males (data
not shown). To further quantify the body size phenotype, we
used RNAi by feeding. In the wild type background, these
animals were the same as controls (data not shown). In the rrf-3
RNAi hypersensitive background (Simmer et al., 2002),
T27F2.4 knockdown resulted in a long body size in adults
and larvae after about 24 h of development (Fig. 4F).
T27F2.4 encodes a basic-leucine zipper transcription factor
homologous to the fos homologs human p21SNFT and mouse
fosB. Fos proteins are dimerization partners with Jun proteins
that bind AP-1 binding sites. JunB is known to be a Smad-
binding partner, and both fos and jun homologs are transcrip-
tionally regulated by TGF-β signaling (Jonk et al., 1998;
Selvamurugan et al., 2004). In addition, the bZIP protein ATF3
is transcriptionally regulated by Smads and subsequently act as
a Smad transcriptional co-factor (Kang et al., 2003). In C.
elegans, four bZIP genes with similarity to vertebrate fos are
identifiable: atf-1, ces-1, fos-1, and T27F2.4, although only
fos-1 may be a true fos ortholog (Sherwood et al., 2005).
Among these, the mutant phenotype of T27F2.4 had not
previously been characterized. Our RNAi and expression
analyses indicate that T27F2.4 is repressed by the DBL-1
pathway and functions as a negative regulator of DBL-1-
regulated body size.
Discussion
SMA-9 transcriptional repressor and activator activities
function differentially in DBL-1 pathway outputs
sma-9 encodes zinc finger transcription factors homologous
to Drosophila Schnurri. We have characterized the transcrip-
tional activities of SMA-9 and conclude that it acts primarily as
a transcriptional repressor in body size regulation, but as both a
transcriptional repressor and activator in male tail patterning.
First, we have shown that the En transcriptional repressor fused
to SMA-9 DNA binding domains can substitute for functional
SMA-9 protein in vivo (Table 1). Detailed examination of the
rescued phenotype showed that En-SMA-9 gives rise to an
overexpression phenotype of male ray 3–4 fusions both in sma-
9 mutants and wild type. Second, we have shown that VP-16-
SMA-9 is dominant negative in body size regulation but
partially rescues male tail defects (Fig. 1; Table 1). Third, we
showed that different sma-9 fragments have different transcrip-tional activities in vitro (Table 2). Given that alternative splicing
exists in sma-9, isoforms containing the N-terminus may act as
transcriptional repressors, while some isoforms, for example
that encoded by yk1237d01, could function as transcriptional
activators in the pathway. Consistent with this hypothesis,
yk1237d01 expression can rescue the sensory ray defect of sma-
9(wk55) to the same extent as the activator fusion VP-16-SMA-
9. The fourth line of evidence comes from our microarray
analysis. Among genes directly or indirectly regulated by sma-
9, more genes are repressed than are activated, consistent with
sma-9 functioning primarily as a transcriptional repressor in
the pathway in early larval stages. Work on Drosophila and
Xenopus Schnurri homologs has demonstrated that transcrip-
tional activation or repression at specific target genes may be
context-dependent (Yao et al., 2006). Our results do not
preclude a context-dependent mechanism, but suggest that
intrinsic properties of the protein products also contribute to the
determination of transcriptional activity.
Our results suggest that transcriptional repression is critical
to the response to DBL-1. Specifically, among dbl-1-regulated
genes, 66% of genes were repressed, suggesting that in early
larval stages the DBL-1 pathway primarily represses target
genes, whether they are SMA-9-dependent or -independent. At
a molecular level, this repression may be mediated by Smad
complexes directly, or by recruitment of transcriptional
repressors such as SMA-9, or by the transcriptional activation
of transcriptional repressor gene(s) that then repress target
genes. In our findings, sma-9 transcription was not regulated by
the DBL-1 pathway itself, but SMA-9 might be recruited by
Smad proteins in order to repress gene transcription. Our work
underscores the importance of investigating both negative and
positive regulation of target genes in response to signaling
pathways.
Genes that regulate body size
The molecular mechanisms by which the DBL-1 pathway
regulates growth are incompletely understood. Two hypotheses
in the literature are that the DBL-1 pathway regulates body size
through controlling collagens and through regulating chromo-
somal ploidy due to endoreduplication in hypodermal cells
(Nystrom et al., 2002; Flemming et al., 2000; Morita et al.,
2002). In our microarray profile, we identified both collagen
genes and cell cycle control genes that might regulate endo-
reduplication (see below). We also identified five target genes
whose loss of function results in demonstrated body size
phenotypes: ptc-3, ptr-22, wrt-4, T27F2.4 (fos-related), and
rnt-1. The latter two are transcription factors that could mediate
indirect modulation of gene expression downstream of DBL-1
signaling. Furthermore, these transcription factors have verte-
brate homologs, fos and Runx, which interact directly with
Smad proteins and are transcriptional targets of TGF-β-related
signaling (Jonk et al., 1998; Selvamurugan et al., 2004). The
loss-of-function phenotype of T27F2.4 is long body size,
suggesting that the negative regulation of this gene may mediate
DBL-1 signaling outputs. On the other hand, the loss-of-
function phenotype of rnt-1 (small body size) and its genetic
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rnt-1 regulates body size solely as a downstream target of
dbl-1. Other conserved interactors that we identified were genes
of the Hedgehog family. Genetic interactions between BMP
pathways and Hedgehog signaling have been extensively
studied in other organisms (Tabata and Takei, 2004), however
little is known in C. elegans. Finally, some novel targets of
DBL-1 signaling were also identified. These include a family of
nine genes containing a domain of unknown function, DUF19
(Supplementary Table 4).
Cell cycle control genes
mcm-7 and cell cycle control genes were downregulated in
dbl-1 but not sma-9 mutants (Table 3). mcm-7 is homologous
to minichromosome maintenance (MCM) proteins that play a
critical role in S phase genome stability. MCM are DNA
replication licensing factors in eukaryotic cells. Studies from
yeast, Xenopus, and mammalian cells demonstrated that MCM
are targets of the S phase checkpoint and are essential for DNA
replication initiation and elongation (Bailis and Forsburg,
2004).
We and others have shown that hyp7, the large hypodermal
syncytium, is a critical tissue for body size development, since
expression of sma-3, sma-6, and lon-1 in hyp7 alone is
sufficient to rescue the respective mutant body size defects
(Wang et al., 2002; Yoshida et al., 2001; Maduzia et al., 2002).
In DBL-1 pathway mutants, the cell number does not change,
indicating that a defect in cell division is not the cause of small
body size (Suzuki et al., 1999; Flemming et al., 2000).
However, several lines of evidence showed that the DNA
content in polyploid hypodermal nuclei due to endoreduplica-
tion was reduced in the pathway mutants (Flemming et al.,
2000; Morita et al., 2002). Perhaps downregulation of mcm-7
blocks endoreduplication in hypodermal cells. Alternatively, the
low expression level of mcm-7 could still be able to allow cell
cycle progression, however it might lengthen the whole process.
Careful investigation of DBL-1 pathway (lf) mutants supports
this idea. Compared with wild-type animals, the development of
Sma mutants is delayed (data not shown). It takes them a longer
time than wild type to develop to the same stage.
Collagens
Collagen genes are another class of dbl-1-regulated, but
sma-9-independent, target genes potentially involved in body
size regulation (Fig. 3; Table 3). Cuticle collagens are
synthesized by the hypodermis and secreted on the surface of
the worm body as an exoskeleton. In the C. elegans genome,
about 175 genes encode collagen-like polypeptides. Mutation of
these genes causes defects in body morphogenesis, e.g. dumpy,
roller, blister, and embryonic lethality (Myllyharju and
Kivirikko, 2004).
The collagen gene lon-3 negatively regulates body size
development as a possible downstream component in the DBL-
1 pathway (Suzuki et al., 2002). Loss of lon-3 function gives
rise to a Lon phenotype. Collagen genes rol-6 and sqt-1genetically interact with one another for animal morphology
(Kramer et al., 1990). It has been reported that both are required
for dbl-1-regulated body length and genetically interact with
lon-3, and these interactions are reciprocal (Nystrom et al.,
2002). In our data rol-6 is downregulated in dbl-1 mutants,
which is consistent with these findings.
Genes related to innate immunity
In this study, we did not expect to identify target genes
involved in male tail patterning, since we analyzed
expression patterns in hermaphrodites during early larval
stages. In addition to genes involved in body size regulation,
however, we likely identified genes with functions in other
outputs of DBL-1 signaling, such as innate immunity, aging,
and germ line regulation (Tables 2–4). DBL-1 pathway
mutants have been shown to be more susceptible to bacterial
infection than wild type animals (Kurz and Tan, 2004). In
our microarray analysis, we identified genes that affect innate
immunity (Mallo et al., 2002; Nicholas and Hodgkin, 2004)
(Fig. 3; Table 3). Similar genes were identified in a previous
smaller-scale study of this pathway using arrayed cDNAs
(Mochii et al., 1999).
Type-C lectins are cell surface proteins capable of binding
carbohydrate (Loris, 2002). In the C. elegans genome, about
135 genes encode a type-C lectin domain. Worms would use
these numerous type-C lectins to recognize different pathogens.
In our array, many type-C lectin genes were regulated by dbl-1
and sma-9 (Tables 2–4) including the genes F35C5.9,
B0218.8, and T07D10.4 (Table 3) identified from previous
studies of this pathway or of dauer pathways (Murphy et al.,
2003; Mochii et al., 1999). Compared with previous reports on
innate immune response (Mallo et al., 2002; Couillault et al.,
2004), nlp-29 and lys-10 expression changed in the opposite
direction. However, nlp-29 was induced specifically upon
bacterial S. marcescens or fungal D. coniospora infection of
adult animals (Couillault et al., 2004), which represents a
pathogen specific response in C. elegans, so expression may
depend on culture conditions. In addition, two members of the
PGP (P-glycoprotein) subclass of ATP-binding cassette (ABC)
transporter family have been identified in our array: pgp-1 and
pgp-6. ABC transporter actively translocates various molecules
across the cell membrane. In humans, its functions include
protecting cells from toxins and resistance to drugs e.g.
antibiotic, anticancer drugs etc (Higgins and Linton, 2004). In
C. elegans, pgp-1(lf) mutants, together with mrp-1 or pgp-3,
were hypersensitive to heavy metals and bacteria, indicating
that pgp-1 plays a role in a defense response. The function of
pgp-6 is still not characterized. In our analysis, all PGP genes
were downregulated in the dbl-1(lf) mutant, which might
contribute to the high susceptibility to bacterial infection of
mutants.
Aging genes
We see altered transcription of genes identified in previous
studies on dauer and aging (Murphy et al., 2003; Liu et al.,
724 J. Liang et al. / Developmental Biology 305 (2007) 714–7252004; Halaschek-Wiener et al., 2005; Table 3). In our array,
genes extending life span were downregulated, namely fat-6;
genes shortening life span were upregulated, namely vit-5 and
vit-6. The dbl-1 mutant has been shown to live shorter than
wild type on standard worm plates using E. coli OP50 as a food
source (Mallo et al., 2002), which is a pathogen for the worm.
The genes that we found affecting aging could also contribute to
a shortened life span. Together, these results support that loss of
function of the DBL-1 pathway leads to a shorter life span in a
diet of OP50.
Germ line genes
In Drosophila, genetic evidence has been provided that
BMP homologs gbb and dpp are essential for maintaining
germ line stem cells (GSC) in the ovary and testis (Kawase
et al., 2004; Song et al., 2004). However, in C. elegans, no
functional relationship between BMP signaling and germ
line development has been previously proposed. Our
microarray data includes many genes affecting germ line
development, including key genes required for meiosis, such
as gld-1 (Table 3). These meiosis-promoting genes are
repressed by dbl-1 and sma-9, as would be expected if dbl-
1 functioned to maintain stem cell identity. These results
point to an evolutionarily conserved role for DBL-1 pathway
signaling in the germ line that had not previously been
recognized.
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